Lytix Biopharma awarded this year’s Nordic Stars Awards
Lytix Biopharma is one of three companies that have been elected for this year's Nordic Stars Awards. The prize was awarded at the closing ceremony Tuesday September 9th 2014 and given to companies that the organizers of the Nordic Life Science Days sees as extra promising. - We have established The Nordic Stars Awards to shed some extra light on those companies that we as organizers see really showcase how innovative Nordic Companies can be, they say.
Nordic Life Science Days in brief Nordic Life Science Days is the Nordic region’s largest partnering conference for the global life science industry. The conference attracts leading decision-makers in the life science sector, including the bioengineering, pharmaceuticals and Med Tech segments, along with investors, research institutions, politicians and authorities. This year’s Nordic Life Science Days event is taking place in partnership with Oslo Cancer Cluster and Toulouse Cancer-Bio-Santé Cluster.
This year they have: 840+ registered delegates 570+ companies/organizations 26 countries represented 7000+ meeting requests in partneringONE 1400+ accepted meetings 480+ licensing opportunities
- This is a great honor, said Unni Hjelmaas, CEO at Lytix Biopharma. - We appreciate that we are noticed in an active Nordic market with many promising companies. To receive such an award makes us aware that others are watching us and gives us an extra motivation to prove that it is possible for innovative Nordic companies to succeed.
- With this price and the attention given to us we have a good basis for dialogue with potential partners. We are very grateful that professionals outside our company believe in what we do, said Knut Eidissen, Chairman of the Board of Lytix Biopharma